EHR-based Universal Medication Schedule to Improve Adherence to Complex Regimens
基于 EHR 的通用用药计划可提高对复杂治疗方案的依从性
基本信息
- 批准号:9980518
- 负责人:
- 金额:$ 54.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-26 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:AdherenceAdultAdverse drug eventBehavior TherapyCaliforniaCellular PhoneChicagoClinical TrialsComplexCost AnalysisDiabetes MellitusDoseDrug PrescriptionsDrug usageElectronic Health RecordEnrollmentFoundationsFutureHealthHealth BenefitHealth systemHealthcareHypertensionInstitute of Medicine (U.S.)InstructionInterventionLabelLanguageLinkMedication ErrorsMedicineMemoryNew YorkNon-Insulin-Dependent Diabetes MellitusOutcomePatient CarePatientsPharmaceutical PreparationsPharmacistsPharmacopoeiasPharmacy facilityPhysiciansPlant RootsPrimary Health CareRandomized Controlled TrialsRegimenResearchRisk FactorsScheduleSelf ManagementSelf MedicationServicesStandardizationStatutes and LawsStructureSystemTechnologyTestingTextText MessagingTimeTreatment outcomeVisitarmbasecosteffectiveness evaluationeffectiveness testingepidemiology studyhealth literacyimprovedintervention costintervention effectliteracyliterateprogramspublic health relevanceskillssocioeconomicstooltreatment as usual
项目摘要
DESCRIPTION (provided by applicant): We will leverage increasingly available technologies to impart a Universal Medication Schedule (UMS) in primary care to help patients living with diabetes safely use and adhere to complex drug regimens. Our research team previously introduced the concept of the UMS to standardize and simplify medication instructions to support safe and effective prescription (Rx) drug use. The UMS standardizes the prescribing and dispensing of medicine by using health literacy principles and more explicit times to describe when to take medicine (morning, noon, evening, bedtime). This eliminates variability found in the way prescriptions are written by physicians and transcribed by pharmacists onto drug bottle labels. We recently tested the UMS in a clinical trial at the point of dispensing medication in pharmacy practice among adults with diabetes. Significant improvement was achieved in proper regimen use and adherence; those who were taking ≥ 5 Rx drugs and/or were lower literate received the greatest benefit. Yet pharmacy was not the ideal point of implementation, as we learned many patients use multiple pharmacies for cost or convenience, resulting in continued receipt of variable Rx information. Further, findings indicate patients 1) may benefit from direct guidance from their doctor on how to safely consolidate Rx regimens to the most efficient daily schedule, and 2) need basic reminders to support memory. In the proposed study, we will impart the UMS at the point of prescribing in primary care using electronic health records (EHRs). As its foundation, our new intervention will standardize prescribing within an EHR so all medication orders include UMS Rx instructions ('sigs') and patients receive both a medication information sheet and UMS-structured medication list with after-visit summaries. We have already successfully developed and pilot tested these tools (in English and Spanish) within the Epic EHR system. In addition, mobile tools may further improve regimen use. We will link a unidirectional short message service (SMS) text reminder service to the EHR, delivering medication reminders to patients around UMS intervals. We propose to conduct a 3-arm, physician-randomized controlled trial to evaluate the effectiveness of the UMS EHR-based strategy, with and without SMS text reminders, to improve patient understanding, safe use and adherence compared to usual care. 1200 (n=400 per arm) English and Spanish-speaking primary care patients living with type 2 diabetes and taking ≥ 5 Rx drugs will be enrolled from primary care practices in Chicago, IL and New York, NY, with outcomes assessed at baseline, 2 weeks, 3 and 6 months. We will also determine the fidelity and costs of the interventions to guide future dissemination efforts. Our specific aims are to: 1) Test the effectiveness of the UMS and UMS + SMS text reminder strategies compared to usual care; 2) Determine if the effects of these UMS strategies vary by patients' literacy skills and language; 3)
Evaluate the fidelity of the two strategies and explore patient, staff, physician, and health syste factors influencing the interventions; and 4) Assess the costs required to deliver either intervention from a health system perspective.
描述(由申请人提供):我们将利用日益可用的技术在初级保健中提供通用用药时间表(UMS),以帮助糖尿病患者安全地使用并坚持复杂的药物治疗方案。我们的研究团队之前引入了 UMS 的概念,以标准化和简化用药说明,以支持安全有效的处方 (Rx) 药物使用。 UMS 通过使用健康素养原则和更明确的时间来描述何时服药(早上、中午、晚上、就寝时间),从而标准化了药物的处方和配药。这消除了医生撰写处方和药剂师转录到药瓶标签上的方式中存在的差异。我们最近在一项临床试验中对 UMS 进行了测试,该试验是在成人糖尿病患者的药房配药过程中进行的。在正确的治疗方案使用和依从性方面取得了显着改善;那些正在服用 ≥ 5 种 Rx 药物和/或文化程度较低的人获得了最大的益处。然而,药房并不是理想的实施点,因为我们了解到,许多患者出于成本或方便的考虑而使用多个药房,导致不断收到可变的处方信息。此外,研究结果表明,患者 1) 可能会受益于医生关于如何安全地将治疗方案巩固为最有效的每日计划的直接指导,2) 需要基本提醒来支持记忆。在拟议的研究中,我们将使用电子健康记录 (EHR) 在初级保健处方时传授 UMS。作为其基础,我们的新干预措施将标准化 EHR 内的处方,以便所有药物订单都包括 UMS Rx 说明(“sigs”),并且患者会收到药物信息表和 UMS 结构的药物清单以及就诊后摘要。我们已经在 Epic EHR 系统中成功开发并试点测试了这些工具(英语和西班牙语)。此外,移动工具可以进一步改善治疗方案的使用。我们将把单向短信服务 (SMS) 文本提醒服务链接到 EHR,在 UMS 间隔期间向患者提供用药提醒。我们建议进行一项三臂、医生随机对照试验,以评估基于 UMS EHR 的策略的有效性,无论是否有短信提醒,与常规护理相比,可提高患者的理解、安全使用和依从性。将从伊利诺伊州芝加哥和纽约州纽约市的初级保健实践中招募 1200 名(每组 400 名)患有 2 型糖尿病并服用 ≥ 5 种 Rx 药物的说英语和西班牙语的初级保健患者,并在基线、2 周、3 和 6 个月时评估结果。我们还将确定干预措施的保真度和成本,以指导未来的传播工作。我们的具体目标是: 1) 测试 UMS 和 UMS + SMS 短信提醒策略与常规护理相比的有效性; 2) 确定这些 UMS 策略的效果是否因患者的读写能力和语言而异; 3)
评估两种策略的保真度,并探索影响干预措施的患者、工作人员、医生和卫生系统因素; 4) 从卫生系统的角度评估实施任一干预措施所需的成本。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alex D Federman其他文献
Natural Language Processing to Identify Patients with Cognitive Impairment
自然语言处理识别认知障碍患者
- DOI:
- 发表时间:
2022 - 期刊:
- 影响因子:0
- 作者:
Khalil I Hussein;Lili Chan;Tielman T. Van Vleck;Kelly Beers;M. R. Mindt;Michael Wolf;Laura M. Curtis;Parul Agarwal;Juan P Wisnivesky;Girish N. Nadkarni;Alex D Federman - 通讯作者:
Alex D Federman
Relationship Between Cognitive Impairment and Depression Among Middle Aged and Older Adults in Primary Care
初级保健中老年人认知障碍与抑郁症的关系
- DOI:
10.1177/23337214231214217 - 发表时间:
2024 - 期刊:
- 影响因子:2.7
- 作者:
Alex D Federman;Jacqueline Becker;Fernando Carnavali;M. Rivera Mindt;Dayeon Cho;Gaurav Pandey;Lili Chan;Laura M. Curtis;Michael S Wolf;Juan P Wisnivesky - 通讯作者:
Juan P Wisnivesky
Alex D Federman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alex D Federman', 18)}}的其他基金
Research Training for the Care of Vulnerable Older Adults with Alzheimer’s Disease and Related Dementias and Other Chronic Conditions
针对患有阿尔茨海默病和相关痴呆症及其他慢性病的弱势老年人的护理研究培训
- 批准号:
10160741 - 财政年份:2020
- 资助金额:
$ 54.13万 - 项目类别:
Natural Language Processing and Automated Speech Recognition to Identify Older Adults with Cognitive Impairment
自然语言处理和自动语音识别可识别患有认知障碍的老年人
- 批准号:
10383696 - 财政年份:2020
- 资助金额:
$ 54.13万 - 项目类别:
Research Training for the Care of Vulnerable Older Adults with Alzheimer’s Disease and Related Dementias and Other Chronic Conditions
针对患有阿尔茨海默病和相关痴呆症及其他慢性病的弱势老年人的护理研究培训
- 批准号:
10427387 - 财政年份:2020
- 资助金额:
$ 54.13万 - 项目类别:
Natural Language Processing and Automated Speech Recognition to Identify Older Adults with Cognitive Impairment
自然语言处理和自动语音识别可识别患有认知障碍的老年人
- 批准号:
10609461 - 财政年份:2020
- 资助金额:
$ 54.13万 - 项目类别:
Research Training for the Care of Vulnerable Older Adults with Alzheimer’s Disease and Related Dementias and Other Chronic Conditions
针对患有阿尔茨海默病和相关痴呆症及其他慢性病的弱势老年人的护理研究培训
- 批准号:
10629300 - 财政年份:2020
- 资助金额:
$ 54.13万 - 项目类别:
EHR-based Universal Medication Schedule to Improve Adherence to Complex Regimens
基于 EHR 的通用用药计划可提高对复杂治疗方案的依从性
- 批准号:
9358340 - 财政年份:2016
- 资助金额:
$ 54.13万 - 项目类别:
Home-based Primary Care for Homebound Seniors: a Randomized Controlled Trial
居家老年人的家庭初级护理:随机对照试验
- 批准号:
9082810 - 财政年份:2016
- 资助金额:
$ 54.13万 - 项目类别:
Obesity and Asthma: Unveiling Metabolic and Behavioral Pathways
肥胖和哮喘:揭示代谢和行为途径
- 批准号:
9127632 - 财政年份:2016
- 资助金额:
$ 54.13万 - 项目类别:
Self-management behaviors among COPD patients with multi-morbidity
多种疾病的慢性阻塞性肺病患者的自我管理行为
- 批准号:
8976686 - 财政年份:2015
- 资助金额:
$ 54.13万 - 项目类别:
Longitudinal study of cognition, health literacy, and self-care in COPD patients
COPD患者认知、健康素养和自我护理的纵向研究
- 批准号:
8490418 - 财政年份:2011
- 资助金额:
$ 54.13万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 54.13万 - 项目类别:
Research Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 54.13万 - 项目类别:
Standard Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 54.13万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 54.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 54.13万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 54.13万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 54.13万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 54.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 54.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 54.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)